MY148219A - Antibacterial quinoline derivatives - Google Patents
Antibacterial quinoline derivativesInfo
- Publication number
- MY148219A MY148219A MYPI20063590A MYPI20063590A MY148219A MY 148219 A MY148219 A MY 148219A MY PI20063590 A MYPI20063590 A MY PI20063590A MY PI20063590 A MYPI20063590 A MY PI20063590A MY 148219 A MY148219 A MY 148219A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- pharmaceutically acceptable
- treatment
- quinoline derivatives
- forms
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000186367 Mycobacterium avium Species 0.000 abstract 1
- 241000187492 Mycobacterium marinum Species 0.000 abstract 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO NOVEL SUBSTITUTED QUINOLINE DERIVATIVES ACCORDING TO THE GENERAL FORMULA (IA) OR FORMULA (IB ): OR THE PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALTS THEREOF, THE QUARTERNARY AMINES THEREOF, THE STEREOCHEMICALLY ISOMERIC FORMS THEREOF, THE TAUTOMERIC FORMS THEREOF AND THE N-OXIDE FORMS THEREOF. THE CLAIMED COMPOUNDS ARE USEFUL FOR THE TREATMENT OF A BACTERIAL DISEASE INCLUDING A MYCOBACTERIAL DISEASE, PARTICULARLY THOSE DISEASES CAUSED BY PATHOGENIC MYCOBACTERIA SUCH AS MYCOBACTERIUM TUBERCULOSIS, M BOVIS, M. AVIUM AND M. MARINUM. ALSO CLAIMED IS A COMPOSITION COMPRISING A PHARMACEUTICALLY ACCEPTABLE CARRIER AND, AS A ACTIVE INGREDIENT, A THERAPEUTICALLY EFFECTIVE AMOUNT OF THE CLAIMED COMPOUNDS, THE USE OF THE CLAIMED COMPOUNDS OR COMPOSITIONS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF BACTERIAL DISEASES AND A PROCESS FOR PREPARING THE CLAIMED COMPOUNDS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106962 | 2005-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY148219A true MY148219A (en) | 2013-03-29 |
Family
ID=35610159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20063590A MY148219A (en) | 2005-07-28 | 2006-07-26 | Antibacterial quinoline derivatives |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7915292B2 (en) |
| EP (1) | EP1912948B1 (en) |
| JP (1) | JP5100647B2 (en) |
| KR (1) | KR101334719B1 (en) |
| CN (1) | CN101273016B (en) |
| AP (1) | AP2322A (en) |
| AR (1) | AR054587A1 (en) |
| AU (1) | AU2006274918B2 (en) |
| BR (1) | BRPI0614122B8 (en) |
| CA (1) | CA2614981C (en) |
| CY (1) | CY1117247T1 (en) |
| DK (1) | DK1912948T3 (en) |
| EA (1) | EA015617B1 (en) |
| ES (1) | ES2554924T3 (en) |
| HR (1) | HRP20151308T1 (en) |
| HU (1) | HUE026259T2 (en) |
| IL (1) | IL188987A0 (en) |
| JO (1) | JO3077B1 (en) |
| MX (1) | MX2008001219A (en) |
| MY (1) | MY148219A (en) |
| NO (1) | NO341795B1 (en) |
| NZ (1) | NZ565946A (en) |
| PL (1) | PL1912948T3 (en) |
| PT (1) | PT1912948E (en) |
| RS (1) | RS54382B1 (en) |
| SI (1) | SI1912948T1 (en) |
| TW (1) | TWI427065B (en) |
| UA (1) | UA94051C2 (en) |
| WO (1) | WO2007014885A1 (en) |
| ZA (1) | ZA200800783B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
| WO2011144444A1 (en) * | 2010-05-21 | 2011-11-24 | Syngenta Participations Ag | Novel amides as fungicides |
| AU2013254670B2 (en) | 2012-04-27 | 2017-03-30 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| ES2576491T3 (en) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Quinoline Antibacterial Derivatives |
| ES2596243T3 (en) * | 2012-08-24 | 2017-01-05 | F. Hoffmann-La Roche Ag | New bicyclic derivatives of pyridine |
| CN104650054B (en) * | 2013-11-25 | 2019-09-13 | 重庆医药工业研究院有限责任公司 | A kind of quinoline thiophene virtue oxygen 1-ethanamine derivatives of anti-tubercle bacillus |
| CN105175329B (en) * | 2014-06-10 | 2017-09-19 | 重庆圣华曦药业股份有限公司 | A kind of shellfish reaches the synthetic route and method of quinoline raceme |
| US20190321324A1 (en) * | 2016-12-30 | 2019-10-24 | Board Of Regents, The University Of Texas System | Quaternary amine antibiotic therapeutics |
| CN110804016B (en) * | 2019-12-05 | 2022-11-04 | 福建省微生物研究所 | Diarylquinoline derivatives against Mycobacterium tuberculosis |
| US20240287022A1 (en) * | 2021-06-28 | 2024-08-29 | Merck Sharp & Dohme Llc | Il4i1 inhibitors and methods of use |
| CN117843568A (en) * | 2024-01-03 | 2024-04-09 | 中国药科大学 | Aralkyl substituted-1-methylquinoline quaternary ammonium salt derivative and preparation method and use thereof |
| CN119666810A (en) * | 2025-02-19 | 2025-03-21 | 吉林国际旅行卫生保健中心(长春海关口岸门诊部) | A method for fluorescence detection of Mycobacterium tuberculosis using tongue swab samples based on image processing |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1041035A3 (en) * | 1982-02-25 | 1983-09-07 | Киорин Сейяку Кабусики Кайся (Фирма) | Process for preparing derivatives of quinolinecarboxylic acid, their hydrates or salts |
| JPS6463518A (en) * | 1987-09-02 | 1989-03-09 | Otsuka Pharma Co Ltd | Antiarrhythmic agent |
| US5235054A (en) * | 1992-07-15 | 1993-08-10 | Pfizer Inc. | 3-carboxaldehyde substituted quinolines and naphthyridines |
| DE69518075T2 (en) * | 1994-05-24 | 2001-03-22 | F. Hoffmann-La Roche Ag, Basel | TRICYCLIC DICARBONYL DERIVATIVES |
| CN1307565A (en) * | 1998-04-29 | 2001-08-08 | 史密丝克莱恩比彻姆有限公司 | Quinolones used as MRS inhibitor and bactericides |
| SI1527050T1 (en) | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Quinoline derivatives and their use as mycobacterial inhibitors |
-
2006
- 2006-07-11 JO JOP/2006/0218A patent/JO3077B1/en active
- 2006-07-26 WO PCT/EP2006/064656 patent/WO2007014885A1/en not_active Ceased
- 2006-07-26 MY MYPI20063590A patent/MY148219A/en unknown
- 2006-07-26 HU HUE06777972A patent/HUE026259T2/en unknown
- 2006-07-26 HR HRP20151308TT patent/HRP20151308T1/en unknown
- 2006-07-26 BR BRPI0614122A patent/BRPI0614122B8/en not_active IP Right Cessation
- 2006-07-26 DK DK06777972.8T patent/DK1912948T3/en active
- 2006-07-26 SI SI200631998T patent/SI1912948T1/en unknown
- 2006-07-26 US US11/996,786 patent/US7915292B2/en active Active
- 2006-07-26 UA UAA200800826A patent/UA94051C2/en unknown
- 2006-07-26 CA CA2614981A patent/CA2614981C/en not_active Expired - Lifetime
- 2006-07-26 NZ NZ565946A patent/NZ565946A/en not_active IP Right Cessation
- 2006-07-26 EA EA200800455A patent/EA015617B1/en unknown
- 2006-07-26 ES ES06777972.8T patent/ES2554924T3/en not_active Expired - Lifetime
- 2006-07-26 JP JP2008523352A patent/JP5100647B2/en not_active Expired - Fee Related
- 2006-07-26 MX MX2008001219A patent/MX2008001219A/en active IP Right Grant
- 2006-07-26 KR KR1020087004457A patent/KR101334719B1/en not_active Expired - Fee Related
- 2006-07-26 CN CN200680035175XA patent/CN101273016B/en not_active Expired - Fee Related
- 2006-07-26 RS RS20150796A patent/RS54382B1/en unknown
- 2006-07-26 PL PL06777972T patent/PL1912948T3/en unknown
- 2006-07-26 AU AU2006274918A patent/AU2006274918B2/en not_active Ceased
- 2006-07-26 AP AP2008004308A patent/AP2322A/en active
- 2006-07-26 EP EP06777972.8A patent/EP1912948B1/en not_active Expired - Lifetime
- 2006-07-26 PT PT67779728T patent/PT1912948E/en unknown
- 2006-07-27 TW TW095127409A patent/TWI427065B/en not_active IP Right Cessation
- 2006-07-27 AR ARP060103260A patent/AR054587A1/en unknown
-
2008
- 2008-01-24 IL IL188987A patent/IL188987A0/en active IP Right Grant
- 2008-01-25 ZA ZA200800783A patent/ZA200800783B/en unknown
- 2008-02-27 NO NO20081008A patent/NO341795B1/en not_active IP Right Cessation
-
2015
- 2015-12-08 CY CY20151101113T patent/CY1117247T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05001052A (en) | Quinoline derivatives and their use as mycobacterial inhibitors. | |
| NO20081008L (en) | Antibacterial quinoline derivatives | |
| TW200608974A (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| JO3271B1 (en) | Antibacterial Quinoline Derivatives | |
| SG166019A1 (en) | Quinoline derivatives and use thereof as mycobacterial inhibitors | |
| UA101305C2 (en) | Antibacterial quinoline derivatives | |
| JO2725B1 (en) | Antibacterial Quinoline Derivatives | |
| WO2005070924A8 (en) | Substituted quinolines and their use as mycobacterial inhibitors | |
| CY1114384T1 (en) | ANTIBACTERIAL PRODUCERS OF KINOLIN | |
| JO2685B1 (en) | Antibacterial Quinoline Derivatives | |
| UA101307C2 (en) | Antibacterial quinoline derivatives | |
| SG166799A1 (en) | Quinoline derivatives as antibacterial agents | |
| MX2023000437A (en) | Benzisoxazole derivative. |